Paris, France

Francedillaois Roblot

This inventor holds 1 USPTO granted patent. Top assignee: Institut Francais De Recherche Scientifique Pour Le Developpment En. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francedillaois Roblot. Retrieved from https://idiyas.com/inventor/francedillaois-roblot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Contributions of Francedillaois Roblot in Medical Research

Introduction

Francedillaois Roblot, an innovative inventor based in Paris, France, has made significant contributions to the field of medical research. Known for his focused work in pharmaceuticals, Roblot has dedicated his expertise to developing treatments for disease.

Latest Patents

Roblot holds a patent for "2-substituted quinolines for the treatment of leishmaniasis." This innovative work aims to combat leishmaniasis, a disease that affects millions globally. His research showcases the importance of targeted chemical compounds in addressing complex health challenges.

Career Highlights

Working at the Institut Français de Recherche Scientifique pour le Développement (IFRSD), Roblot has aligned his career with cutting-edge research and development. His professional journey reflects a commitment to improving human health through science and innovation.

Collaborations

Throughout his career, Roblot has collaborated with notable colleagues including Alain Fournet and Alcira Angelo Barrios. These professional partnerships emphasize the collaborative nature of scientific research and the sharing of ideas to drive inventions forward.

Conclusion

Francedillaois Roblot's work exemplifies the intersection of innovation and healthcare. Through his patent and collaboration with esteemed professionals, he continues to influence the landscape of medical treatments, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…